Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Raw Materials (2016 - 2025)

Historic Raw Materials for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $21.0 million.

  • Lemaitre Vascular's Raw Materials rose 324.76% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 324.76%. This contributed to the annual value of $19.1 million for FY2024, which is 423.28% up from last year.
  • According to the latest figures from Q3 2025, Lemaitre Vascular's Raw Materials is $21.0 million, which was up 324.76% from $21.7 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Raw Materials ranged from a high of $21.7 million in Q2 2025 and a low of $4.7 million during Q3 2021
  • Over the past 5 years, Lemaitre Vascular's median Raw Materials value was $18.2 million (recorded in 2023), while the average stood at $15.3 million.
  • In the last 5 years, Lemaitre Vascular's Raw Materials crashed by 791.59% in 2021 and then surged by 18636.95% in 2022.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Raw Materials stood at $5.9 million in 2021, then soared by 151.12% to $14.9 million in 2022, then grew by 22.8% to $18.3 million in 2023, then grew by 4.23% to $19.1 million in 2024, then rose by 9.81% to $21.0 million in 2025.
  • Its last three reported values are $21.0 million in Q3 2025, $21.7 million for Q2 2025, and $20.2 million during Q1 2025.